Urology Robotic Surgery Market Report 2026

The urology robotic surgery market size has grown rapidly in recent years. It will grow from $4.94 billion in 2025 to $5.58 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increasing prevalence of prostate and kidney disorders, wider acceptance of minimally invasive surgery, rising investments in surgical robotics, expansion of specialized urology centers, improvements in robotic system reliability.

The urology robotic surgery market size is expected to see rapid growth in the next few years. It will grow to $8.95 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to growing adoption of next-generation robotic platforms, increasing integration of ai-assisted surgical planning, rising demand for outpatient robotic procedures, expansion of surgeon training programs, continued technological advancements in robotic instrumentation. Major trends in the forecast period include increasing adoption of robotic-assisted urology procedures, rising use of advanced surgical navigation systems, growing integration of simulation-based surgeon training, expansion of minimally invasive treatment approaches, enhanced focus on surgical precision and outcomes.

The rising prevalence of urological disorders is expected to drive the growth of the urology robotic surgery market in the coming years. Urological disorders are conditions affecting the urinary tract and male reproductive organs. This increase is primarily driven by the aging population, as advancing age weakens bladder and pelvic muscles, heightening the risk of such disorders. Urology robotic surgery provides precise, minimally invasive treatment options that enhance surgical accuracy, reduce complications, and improve recovery for conditions such as prostate cancer and kidney disease. For example, in January 2025, Prostate Cancer UK reported that in England, 50,751 men were diagnosed with prostate cancer in 2022, rising to 55,033 in 2023. Consequently, the growing prevalence of urological disorders is supporting the expansion of the urology robotic surgery market.

Leading companies in the urology robotic surgery market are increasingly incorporating artificial intelligence (AI)-powered features to strengthen their competitive position. AI-enabled solutions in urologic robotics include real-time image guidance for tumor identification, 3D surgical planning, and intraoperative skill assessment, all aimed at improving precision and outcomes. For instance, in August 2024, PROCEPT BioRobotics, a US-based surgical robotics company, received FDA clearance for the HYDROS Robotic System, an advanced AI-powered platform designed to enhance Aquablation therapy for benign prostatic hyperplasia (BPH). The system combines AI-driven treatment planning, next-generation imaging, and robotic-assisted, heat-free waterjet tissue resection to remove prostate tissue precisely while preserving critical anatomy. It also optimizes surgical workflow and operating room efficiency. HYDROS is intended to deliver consistent, personalized, and durable symptom relief with better preservation of sexual and urinary function, representing a significant advancement in BPH treatment.

In August 2024, KARL STORZ SE & Co. KG, a Germany-based provider of endoscopy and minimally invasive surgical solutions, acquired Asensus Surgical, Inc. for an undisclosed amount. Through this acquisition, KARL STORZ aims to integrate Asensus Surgical’s digital laparoscopic platform into its portfolio, enhancing surgical precision, intelligence, and workflow efficiency in operating rooms worldwide. Asensus Surgical Inc. is a US-based medical device company offering robotic urology surgery through its Senhance Surgical System.

Major companies operating in the urology robotic surgery market are Siemens Healthineers, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical Inc., KARL STORZ SE & Co. KG, Sina Robotics and Medical Innovators Co. Ltd., CMR Surgical Limited, SS Innovations International Inc., Distalmotion SA, Ronovo Surgical Inc., Levita Magnetics International Corp., Titan Medical Inc., Virtual Incision Corporation, Nanjing Perlove Medical Equipment Co. Ltd., Edge Medical Robotics Corporation, Rob Surgical Systems S.L, Virtuoso Surgical Inc., GynoBotics Inc., Harbin Sagebot Intelligent Medical Equipment Co. Ltd., Perlove Medical Robot.

North America was the largest region in the urology robotic surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urology robotic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urology robotic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the urology robotic surgery market by increasing costs of imported robotic systems, precision instruments, imaging components, and electronic control units. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-value robotic platforms, while Asia-Pacific faces increased manufacturing and export costs. These tariffs are elevating capital investment requirements and slowing procurement cycles for advanced surgical systems. However, they are also encouraging local assembly, regional component sourcing, and innovation in cost-efficient robotic surgery solutions.

The urology robotic surgery market research report is one of a series of new reports that provides urology robotic surgery market statistics, including urology robotic surgery industry global market size, regional shares, competitors with a urology robotic surgery market share, detailed urology robotic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the urology robotic surgery industry. This urology robotic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Urology robotic surgery is a minimally invasive technique in which specialized robotic systems assist urologists in performing precise procedures through small incisions. The surgeon operates robotic arms from a console, gaining enhanced dexterity and three-dimensional visualization, which minimizes damage to surrounding tissues. This approach is commonly used to treat conditions such as prostate, kidney, and bladder cancers.

The primary types of urology robotic surgery include robotic systems, navigation systems, planners, simulators, and others. Robotic surgery systems are advanced machines designed to aid surgeons in performing accurate urological procedures. Key components include the robotic systems themselves, surgical instruments and accessories, and associated services. These systems are applied in procedures such as robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy, and more, serving major end users including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The urology robotic surgery market includes revenues earned by entities by providing services such as preoperative planning, intraoperative imaging, robotic system maintenance, remote surgical assistance, and training and education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The urology robotic surgery market also consists of sales of products, such as surgical visualization systems, haptic feedback devices, robotic arm components, sterile drapes, and software integration tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.